-
Colorectal cancer is now the most common cause of cancer deaths in the US for people under 50The American Cancer Society estimates that over 55,000 people will die from colorectal cancer in the U.S. this year. Of those, 7% will be under 50.
10 Commentscancer -
Cancer vaccine shows promise against HPV-related throat tumors in early studyIf proven effective in humans, the vaccine could complement standard therapies for HPV-driven cancer, as well as inform the design of therapeutic vaccines for other diseases.
cancer -
AI-supported breast cancer screening spots more cancers earlier, landmark trial findsA clinical trial shows that AI-assisted mammography can detect more cases of dangerous cancer and reduce missed diagnoses.
cancer -
New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study findsBy targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and prevented the cancer from returning, a promising step toward overcoming treatment resistance.
9 Commentscancer -
Color blindness linked to lower bladder cancer survival, early study hintsPeople with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed later, a study suggests.
5 Commentscancer -
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?Blood tests that look for over a dozen cancers are being developed. But how soon will they help patients?
cancer -
It matters what time of day you get cancer treatment, study suggestsGiving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.
cancer -
Widespread cold virus you've never heard of may play key role in bladder cancerScientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a host immune system enzyme that attacks DNA.
cancer -
Science history: Female chemist initially barred from research helps develop drug for remarkable-but-short-lived recovery in children with leukemia — Dec. 6, 1954In December 1954, Gertrude Elion and colleagues described a new compound they had developed that sent children with leukemia into remission. It would guide a new approach to "rational drug design."
12 Commentscancer
